D-dimer/Fibrinogen ratio and recurrent exacerbations might have a potential impact to predict 90-day mortality in

Cihan Aydin1, Birsen Pınar Yıldız1, Didem Görgün Hattatoğlu1

  • 1University of Health Sciences, Yedikule Chest Disease and Thoracic Surgery Training and Research Hospital, İstanbul, Turkey.

Insights

The D-dimer/Fibrinogen ratio is a key predictor of 90-day mortality in acute exacerbation of COPD (AECOPD) patients. Recurrent exacerbations also significantly increase mortality risk.

Area of Science:

  • Pulmonology
  • Critical Care Medicine
  • Internal Medicine

Background:

  • Chronic Obstructive Pulmonary Disease (COPD) is a major global health concern, ranking as the third leading cause of death worldwide by 2020.
  • Acute exacerbations of COPD (AECOPD) are critical events associated with significant morbidity and mortality.

Purpose of the Study:

  • To identify prognostic predictors of 90-day mortality following an initial AECOPD event.
  • To elucidate risk factors influencing short-term survival in AECOPD patients.

Main Methods:

  • Multivariable regression analysis was employed to assess various clinical and laboratory parameters.
  • Key factors analyzed included Charlson Comorbidity Score (CCS), readmission rates, D-dimer/Fibrinogen ratio, and exacerbation frequency.

Main Results:

  • The D-dimer/Fibrinogen ratio > 0.11 was significantly associated with increased 90-day mortality (HR: 2.47, p<0.05).
  • Recurrent exacerbations post-discharge (HR: 2.25, p<0.001) and each unit increase in acute exacerbation severity (HR: 3.39, p<0.001) were strong predictors of 90-day mortality.
  • Increased CCS and readmission predicted 30-day mortality.

Conclusions:

  • The D-dimer/Fibrinogen ratio is a critical, independent predictor of 90-day mortality in AECOPD.
  • While D-dimer alone and recurrent exacerbations were implicated, the ratio proved more impactful. Early identification of these predictors can aid in risk stratification and management.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
60
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
443
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.0K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.5K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.0K